Polices and Financials
of Subsidiaries

Policies and Subsidiary Financials

Sequent Scientific Limited is India’s leading animal health company.

Vila Viña Participacions S.L. FY 23-24

  • 2023-2024

Topkim Topkapi ilac Premiks Sanayi Ve Ticaret Anonik Sirketi FY 23-24

  • 2023-2024

Phytotherapic Solutions S. L. FY 23-24

  • 2023-2024

Fendigo SA Belgium FY 23-24

  • 2023-2024

Topkim March 2024 Full set V2.signed

  • 2023-2024

VVP Stat Financials Q4 FY23-24 signed

  • Q4
  • 2023-2024

Phyto Stat Financials Q4 FY23-24 signed

  • Q4
  • 2023-2024

Bremer Pharma GMBH Germany FY 23-24

  • 2023-2024

Alivira Italia S.R.L. Ltda. FY 23-24

  • 2023-2024

N-vet FS FY 23-24

  • 2023-2024

Kz Spain Stat Financials Q4 FY23-24 signed

  • Q4
  • 2023-2024

Provet March 2024 Full set V2.signed

  • 2023-2024

Kz Mexico Stat Financials Kz Mexico Stat Financials Q4 FY23-24 signed

  • Q4
  • 2023-2024

Financials Sequent Scientific ESOP trust FY 2023-24

  • 2023-2024

Fendigo BV FS FY 23-24

  • 2023-2024

Expeden Financials Mar-24

  • 2023-2024

Alivira USA FS FY 23-24

  • 2023-2024

Alivira UK Mar’24

  • 2023-2024

Alivira Saúde Financials Mar-24

  • 2023-2024

Alivira Ireland FS FY 23-24

  • 2023-2024

Alivira Brazil Financials Mar-24

  • 2023-2024

Alivira Animal Health Limited 2023-24

  • 2023-2024

Sequent Research Limited 2023-24

  • 2023-2024

Alivira Animal Health Limited 2022-23

  • 2022-2023

Sequent Research Limited 2022-23

  • 2022-2023

Alivira Animal Health Limited, Ireland Financial Mar’23

  • 2022-2023

Alivira Italia SRL Financial Mar’23

  • 2022-2023

Alivira Saude Animal Brasil Participacoes Ltda Financial Mar’23

  • 2022-2023

Alivira Saude Animal Ltda Financial Mar’23

  • 2022-2023

Bremer Pharma GMBH Financial Mar’23

  • 2022-2023

Fendigo BV Financial Mar’23

  • 2022-2023

Fendigo SA Financial Mar’23

  • 2022-2023

Evanvet Distribuidora De Produtos Veterinarios Ltda Financial Mar’23

  • 2022-2023

Alivira Animal Health USA LLC Financial Mar’23

  • 2022-2023

Alivira Animal Health UK Ltd Financial Mar’23

  • 2022-2023

Laboratorios Karizoo, S.A. DE C.V. (Mexico) Financial Mar’23

  • 2022-2023

Laboratorios Karizoo, S.A Financial Mar’23

  • 2022-2023

N-Vet Financial Mar’23

  • 2022-2023

Phytotherapic Solutions S.L Financial Mar’23

  • 2022-2023

Covivet Stat Financials Q4 FY22-23 signed

  • 2022-2023

Provet Veteriner Ürünleri San. Ve Tic. A. Ş Mar’23

  • 2022-2023

Topkim Topkapi İlaç Premiks Sanayl Ve Ticaret. A. Ş Financials Mar’23

  • 2022-2023

Vila Viña Participacions S.L Financial Mar’23

  • 2022-2023

Alivira Animal Health Limited 2021-22

  • 2021-2022

Sequent Research Limited 2021-22

  • 2021-2022

Alivira Animal Health Limited, Ireland Financial Mar’22

  • 2021-2022

Alivira France SAS Financial Mar’22

  • 2021-2022

Alivira Italia SRL Financial Mar’22

  • 2021-2022

Alivira Saude Animal Brasil Participacoes Ltda Financial Mar’22

  • 2021-2022

Alivira Saude Animal Ltda Financial Mar’22

  • 2021-2022

Bremer Pharma GMBH Financial Mar’22

  • 2021-2022

Fendigo BV Financial Mar’22

  • 2021-2022

Fendigo SA Financial Mar’22

  • 2021-2022

Evanvet Distribuidora De Produtos Veterinarios Ltda Financial Mar’22

  • 2021-2022

Alivira Animal Health USA LLC Financial Mar’22

  • 2021-2022

Alivira Animal Health UK Ltd Financial Mar’22

  • 2021-2022

Laboratorios Karizoo, S.A. DE C.V. (Mexico) Financial Mar’22

  • 2021-2022

Laboratorios Karizoo, S.A Financial Mar’22

  • 2021-2022

N-Vet Financial Mar’22

  • 2021-2022

Phytotherapic Solutions S.L Financial Mar’22

  • 2021-2022

Provet Veteriner Ürünleri San. Ve Tic. A. Ş Mar’22

  • 2021-2022

Topkim Topkapi İlaç Premiks Sanayl Ve Ticaret. A. Ş Financials Mar’22

  • 2021-2022

Nourrie Saude e Nutricao Animal Ltda Financial as on Mar’22

  • 2021-2022

Vila Viña Participacions S.L Financial Mar’22

  • 2021-2022

Alivira Animal Health Limited 2020-21

  • 2020-2021

Sequent Research Limited 2020-21

  • 2020-2021

Elysian Life Sciences Private Limited 2020-21

  • 2020-2021

Alivira Animal Health Limited, Ireland

  • 2020-2021

Alivira France SAS

  • 2020-2021

Alivira Italia SRL

  • 2020-2021

Alivira Saude Animal Brasil Participacoes Ltda

  • 2020-2021

Bremer Pharma GMBH

  • 2020-2021

Evance Saude Animal LTDA

  • 2020-2021

Fendigo BV

  • 2020-2021

Fendigo SA

  • 2020-2021

Evanvet Distribidora Productos Veterinarios Ltda

  • 2020-2021

Alivira Animal Health USA LLC

  • 2020-2021

Alivira Animal Health UK Ltd

  • 2020-2021

Laboratorios Karizoo, S.A. DE C.V. (Mexico)

  • 2020-2021

Laboratorios Karizoo, S.A.

  • 2020-2021

N-VET AB

  • 2020-2021

Phytotherapic Solutions S.L

  • 2020-2021

Provet Veteriner Ürünleri San. Ve Tic. A. Ş.

  • 2020-2021

Topkim İlaç Premiks San. ve Tic. A. Ş.

  • 2020-2021

Veterinaria De Lleida S.L

  • 2020-2021

Vila Viña Participacions S.L.

  • 2020-2021

Alivira Animal Health Limited 2019-20

  • 2019-2020

Sequent Research Limited 2019-20

  • 2019-2020

Elysian Life Sciences Private Limited 2019-20

  • 2019-2020

Alivira Animal Health Limited, Ireland

  • 2019-2020

Alivira France SAS

  • 2019-2020

Alivira Italia SRL

  • 2019-2020

Alivira Saude Animal Brasil Participacoes Ltda

  • 2019-2020

Bremer Pharma GMBH

  • 2019-2020

Evance Saude Animal LTDA

  • 2019-2020

Fendigo BV

  • 2019-2020

Fendigo SA

  • 2019-2020

Interchange Veterinária Indústria E Comércio Ltda.

  • 2019-2020

Laboratorios Karizoo, S.A. DE C.V. (Mexico)

  • 2019-2020

Laboratorios Karizoo, S.A.

  • 2019-2020

Sequent Scientific Limited Employee Stock option Plan 2020.pdf

Prevention of Sexual Harassment (PoSH) Policy

Sequent Corporate Social Responsibility Policy

Policy on Prevention of Harassment & Discrimination

Board Diversity Policy

Sequent code of conduct for prohibition of insider trading

Sequent Whistle Blower Policy

Code of Conduct for Fair Disclosure of Unpublished Price Sensitive Information

EHS Policy

Sequent Policy on Preservation and Archival of Documents.

Sequent Dividend Distribution Policy

Policy on Director’s Appointment and Remuneration

Sequent Policy on Determination of Materiality for Disclosure of Events or Information

Policy on Determination of Material Subsidiaries

Policy on Related Party Transactions

Risk Management Policy

Code of Conduct for Senior Management

Supplier Code of Conduct

Board of Directors

Familiarisation programme for Independent Director

Terms and Conditions of Independent Directors

Familiarisation programme for Independent Director 2023-2024
SeQuent Scientific Limited (BSE: 512529, NSE: SEQUENT), headquartered in India, operates in Animal Health market with a global footprint. SeQuent has seven manufacturing facilities based in India, Spain, Brazil and Turkey with approvals from international regulatory bodies, including USFDA, EUGMP, WHO, TGA, etc. SeQuent currently produces APIs and Animal health formulations in over 100 countries and has more than 1,500 employees.

Investor Relation

Company

Privacy & Policy

© 2025 Sequent. All rights reserved

Crafted by : Version-Next